Furthermore, Yang et al. [14] identified the overexpression of SUMO-activating enzyme subunit 1 (SAE1) in glioma tissues, correlating with higher malignancy grades and poor overall survival (OS). This evidence concerns the gene SAE1 and central nervous system cancer.